Oligometastatic Cancer: When Limited Spread Changes the Plan

Oligometastatic cancer is a form of cancer where the disease has spread to a small number of locations, usually no more than five. Unlike widespread metastatic cancer, some people with oligometastatic cancer may benefit from treatments that target each visible tumour, such as surgery or focused radiation, in combination with systemic therapy. Early assessment by a multidisciplinary cancer team is important to determine the most appropriate treatment plan.

In this blog, we cover what oligometastatic cancer is, how it is diagnosed, why it differs from widespread metastatic disease, the treatment options available, and which patients may benefit from a more targeted treatment approach.

The Importance of Understanding Oligometastatic Cancer

For many years, cancer that had spread beyond its original site was considered incurable and was treated mostly with medicines that worked throughout the body. But doctors have learned that not all metastatic cancers behave the same.

Some patients develop only a few metastases, in a limited number of sites. This condition is called oligometastatic cancer. In selected patients, treating the primary tumour along with all metastatic lesions can improve survival, delay disease progression and sometimes provide long periods without active disease. This has altered the way many cancer specialists approach treatment.

What Is Oligometastatic Disease?

Oligometastatic cancer is an intermediate state between localised cancer and widely metastatic cancer. The word “oligo” means “few,” and this refers to the limited number of metastatic sites.

There is no universal definition of oligometastatic disease, but most specialists agree that a patient with one to five metastases in distant areas, who is potentially amenable to local therapy of all visible tumours, has oligometastatic disease.

This can happen in a variety of ways:

• Cancer is first diagnosed with limited spread.
• Cancer comes back after earlier treatment with just a few metastatic sites.
• Systemic treatment decreases diffuse disease until only a few active lesions are present.

Because treatment choices can differ for each situation, every case must be carefully assessed.

How Is Oligometastatic Cancer Diagnosed?

Diagnosis is more than just counting metastatic tumours. Doctors also consider how far the cancer has spread, how fast it is growing and the overall health of the patient.

Accurate imaging is critical, because detecting all active tumours is necessary for treatment planning.

Oligometastatic Presentation in Various Cancers

Several cancers may evolve to an oligometastatic stage:

• Lung cancer
• Breast cancer
• Colon and rectal cancer
• Prostate cancer
• Kidney cancer
• Melanoma
• Some head and neck cancers

Not all patients with these cancers will have oligometastatic disease, but selected patients may be candidates for aggressive treatment to control all known sites of cancer.

How Is Treatment Different?

The main difference is that doctors can add local treatment for each tumour they can see, alongside systemic therapy.

Systemic Therapy

Systemic treatment affects cancer cells throughout the body and may include:

• Chemotherapy
• Immunotherapy
• Targeted therapy
• Hormone therapy, as indicated

These drugs work to control cancer that could be too small to be seen on scans.

Local Therapy

If it is safe to treat all sites of metastasis, doctors may recommend:

• Surgery to remove metastatic cancer
• Stereotactic Body Radiation Therapy (SBRT), which delivers highly focused radiation
• Radiofrequency or microwave ablation in selected cases

The choice depends on tumour size, location and the overall condition of the patient.

Who May Be Treated Aggressively?

Not all metastatic cancer patients are candidates for local therapy. Doctors usually consider several things, including:

• Few metastatic lesions
• Tumours in treatable sites
• A primary cancer that is controlled or removable
• Good physical condition
• Disease that grows slowly
• No evidence of widespread microscopic progression

Each case is often discussed in a multidisciplinary tumour board before recommendations are made.

What Are the Potential Benefits?

Results vary from patient to patient, but studies show that carefully chosen patients may have:

• Longer progression-free survival
• Improved overall survival
• Better symptom control
• A delay before further systemic therapy is needed
• In some cases, an improved quality of life

It should be noted that the results depend on the type of cancer, the biology of the tumour and the individual’s health.

Are There Any Limits?

Oligometastatic cancer treatment is not an option for all patients. Visible tumours may be successfully treated, but microscopic cancer cells may remain elsewhere in the body.

This usually means patients will need:

• Regular follow-up imaging
• Further medical treatment as necessary
• Long-term monitoring for recurrence

In choosing a treatment, the potential benefits must always be weighed against the potential risks and side effects.

Why a Multidisciplinary Team Matters

A team of specialists from different fields is required in the management of oligometastatic cancer. Medical oncologists, radiation oncologists, surgical oncologists, radiologists, pathologists and other healthcare professionals review imaging, pathology reports and treatment options to develop an individualised plan.

This joint approach helps make sure that all appropriate treatment options are considered and that avoidable procedures are not performed.

Visit the National Cancer Institute for more information about metastatic cancer and current treatment approaches.

Consult Today

If you or someone you care about has been diagnosed with cancer that has spread to only a few places, an expert evaluation can help decide whether advanced local treatments are a reasonable option. The multidisciplinary team at Oncare Cancer Hospital thoroughly reviews the patient’s condition and creates an individualised treatment plan based on the most recent evidence, general health and individual treatment goals.

Disclaimer

This article is for educational purposes only and should not be used as a substitute for professional medical advice, diagnosis or treatment. Every cancer diagnosis is different. Always discuss symptoms, investigations and the most suitable treatment options for your particular condition with a qualified oncologist.